+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rotary-Cutting Biopsy System for Breast Lesion Market by Guidance Technique, Product Type, End User, Lesion Type, Distribution Channel - Global Forecast to 2030- Product Image
Rotary-Cutting Biopsy System for Breast Lesion Market by Guidance Technique, Product Type, End User, Lesion Type, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Rotary-Cutting Biopsy System for Breast Lesion Market by Guidance Technique, Product Type, End User, Lesion Type, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081366
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Rotary-cutting biopsy systems are reshaping breast lesion diagnostics through integrated imaging, precise tissue sampling, and streamlined procedures. Senior healthcare stakeholders will benefit from a focused analysis of evolving technologies, regulatory developments, and operational trends that drive the sector’s rapid transformation. This page offers an actionable overview of the rotary-cutting biopsy system market to empower confident, informed investment and procurement decisions.

Market Snapshot: Rotary-Cutting Biopsy System Market

The rotary-cutting biopsy system market is experiencing robust growth, propelled by ongoing digital integration, demand for minimally invasive procedures, and technological advancements in imaging and automation. Radiologists and surgeons increasingly rely on these systems for enhanced accuracy and reduced patient discomfort. The adoption of AI-assisted targeting and portable devices is expanding access and driving innovation among established manufacturers and emerging companies. The market continues to evolve in response to changing tariffs and regional healthcare investments, pointing toward a dynamic competitive environment for decision-makers.

Scope & Segmentation

This research report examines the key segments, regions, and technological drivers shaping the rotary-cutting biopsy system market:

  • Guidance Techniques: CT, MRI, Stereotactic (Automated, Manual), Ultrasound (Portable, Stationary)
  • Product Types: Disposable Blades, Reusable Handles
  • End User Types: Ambulatory Surgical Centers (Clinic Based, Standalone), Diagnostic Centers (Hospital Affiliated, Standalone), Hospitals (Private, Public)
  • Lesion Types: Cystic Lesions, Microcalcifications, Non-Palpable Lesions, Palpable Lesions
  • Distribution Channels: Direct Sales, Distributors (Online, Value-Added)
  • Geographical Coverage: Americas (including United States regions such as California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (spanning United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Profiles: Hologic, Inc., Becton, Dickinson and Company, Devicor Medical Products, Inc., Merit Medical Systems, Inc., Argon Medical Devices, Inc., Cook Medical LLC, Cardinal Health, Inc., Terumo Corporation, Misonix, Inc., Medtronic plc

Key Takeaways & Strategic Insights

  • Integration of advanced imaging and modular platform design enables seamless device upgrades and adaptation to new clinical protocols.
  • Regional differences in reimbursement and healthcare infrastructure drive adoption patterns and require flexible commercial and service models.
  • Automation, miniaturization, and AI-assistance in targeting are enhancing both precision and procedural efficiency for diverse clinical settings.
  • Leading manufacturers are strengthening positions through global networks and R&D, while emerging disruptors target niche and underserved markets.
  • Hospital administrators and procurement teams increasingly evaluate total cost of ownership, factoring in both procedural efficiency gains and equipment life cycle management.
  • Partnerships both among device firms and with software developers are producing integrated offerings that leverage workflow analytics and maintenance forecasting to deliver value beyond equipment sales.

Tariff Impact on Supply Chain and Procurement

The introduction of new tariffs in 2025 has raised landed costs for biopsy components and accessories in the United States. Manufacturers have responded by localizing production and optimizing shipment strategies. Healthcare providers are reassessing procurement models, considering holistic cost assessments that account for clinical efficiencies and ongoing device utilization. The industry’s ability to adapt through strategic sourcing and transparent vendor communication will influence both pricing stability and market growth in a tariff-affected environment.

Methodology & Data Sources

Research findings are based on structured interviews with clinical, procurement, and engineering professionals, as well as secondary analysis of published clinical literature, patent databases, regulatory filings, and company disclosures. Quantitative trends were synthesized from official shipment data, import-export records, and corroborated hospital procurement information. The methodology emphasizes triangulation and expert peer review to ensure reliable insights.

Why This Report Matters

  • Identifies technology and business model trends for stakeholders evaluating rotary-cutting biopsy investments.
  • Clarifies emerging competitive strategies and procurement considerations shaped by new tariffs and evolving reimbursement.
  • Supports informed design and sourcing decisions by mapping segmentation and innovation across diverse regional markets.

Conclusion

Rotary-cutting biopsy systems are central to advancing precision diagnostics and improved breast care. Market leaders poised for growth will prioritize modular technology, resilient supply strategies, and service excellence to match shifting healthcare and regulatory needs.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Rotary-Cutting Biopsy System for Breast Lesion Market, by Guidance Technique
8.1. Introduction
8.2. Ct
8.3. Mri
8.4. Stereotactic
8.4.1. Automated Stereotactic
8.4.2. Manual Stereotactic
8.5. Ultrasound
8.5.1. Portable Ultrasound
8.5.2. Stationary Ultrasound
9. Rotary-Cutting Biopsy System for Breast Lesion Market, by Product Type
9.1. Introduction
9.2. Disposable Blades
9.3. Reusable Handles
10. Rotary-Cutting Biopsy System for Breast Lesion Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Clinic Based Ambulatory Surgical Centers
10.2.2. Standalone Ambulatory Surgical Centers
10.3. Diagnostic Centers
10.3.1. Hospital Affiliated Diagnostic Centers
10.3.2. Standalone Diagnostic Centers
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Rotary-Cutting Biopsy System for Breast Lesion Market, by Lesion Type
11.1. Introduction
11.2. Cystic Lesions
11.3. Microcalcifications
11.4. Non Palpable Lesions
11.5. Palpable Lesions
12. Rotary-Cutting Biopsy System for Breast Lesion Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.3.1. Online Distributors
12.3.2. Value Added Distributors
13. Americas Rotary-Cutting Biopsy System for Breast Lesion Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Rotary-Cutting Biopsy System for Breast Lesion Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Hologic, Inc.
16.3.2. Becton, Dickinson and Company
16.3.3. Devicor Medical Products, Inc.
16.3.4. Merit Medical Systems, Inc.
16.3.5. Argon Medical Devices, Inc.
16.3.6. Cook Medical LLC
16.3.7. Cardinal Health, Inc.
16.3.8. Terumo Corporation
16.3.9. Misonix, Inc.
16.3.10. Medtronic plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET MULTI-CURRENCY
FIGURE 2. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET MULTI-LANGUAGE
FIGURE 3. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATED STEREOTACTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MANUAL STEREOTACTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PORTABLE ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATIONARY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISPOSABLE BLADES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY REUSABLE HANDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CLINIC BASED AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STANDALONE AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITAL AFFILIATED DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STANDALONE DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CYSTIC LESIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MICROCALCIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY NON PALPABLE LESIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PALPABLE LESIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ONLINE DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY VALUE ADDED DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 69. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 70. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 71. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 74. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 75. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 76. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 77. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 82. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 135. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 136. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 137. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 138. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 141. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 142. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 144. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. GERMANY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 148. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 149. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 153. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 155. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. FRANCE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 168. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 169. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 170. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 171. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 174. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 175. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 177. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. ITALY ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 179. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 180. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 181. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 182. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 185. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 186. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 188. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. SPAIN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 223. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 224. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 225. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 226. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 229. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 230. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 231. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 232. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. DENMARK ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 245. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 246. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 247. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 248. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 251. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 252. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 253. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY LESION TYPE, 2018-2030 (USD MILLION)
TABLE 254. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. QATAR ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 256. FINLAND ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 257. FINLAND ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 258. FINLAND ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 259. FINLAND ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. FINLAND ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. FINLAND ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 262. FINLAND ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Rotary-Cutting Biopsy System for Breast Lesion market report include:
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • Devicor Medical Products, Inc.
  • Merit Medical Systems, Inc.
  • Argon Medical Devices, Inc.
  • Cook Medical LLC
  • Cardinal Health, Inc.
  • Terumo Corporation
  • Misonix, Inc.
  • Medtronic plc

Related Topics

Related Reports

Breast Cancer Screening Device Market by Technology, Application, End User - Global Forecast to 2030 - Product Image

Breast Cancer Screening Device Market by Technology, Application, End User - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Breast Cancer Diagnostics - Global Strategic Business Report - Product Image

Breast Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From
Breast Cancer Liquid Biopsy Testing Devices Market by Technology, Application, End User, Test Type, Sample Type, Indication, Distribution Channel - Global Forecast to 2030 - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market by Technology, Application, End User, Test Type, Sample Type, Indication, Distribution Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033 - Product Image

Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033

  • Report
  • 145 Pages
  • Global
From
Breast Cancer Diagnostics Market Report 2025 - Product Image

Breast Cancer Diagnostics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.